Company intelligence / Profile preview

First Derm

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

First Derm offers an anonymous, on-demand teledermatology service connecting users to board-certified dermatologists via web or mobile app. Over 200,000 cases have been reviewed with high sensitivity and specificity for diagnosis. About 70% of cases can be managed with over-the-counter products; the remainder are referred for in-person care. The service has demonstrated clinical value in early detection of serious conditions like melanoma.

Therapeutic areas: OncologyDermatologyImmunologyInfectious Diseases
Modalities: Non-pharmacological therapy (teledermatology consultation)
Industry: Non-Academic Healthcare

Partnerships

South Cheshire and Vale Royal GP Alliance & Howbeck Healthcare (UK pilot project)

Beyond the preview

Go deeper on First Derm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on First Derm.

Explore the full profile